Brief: Coag-Sense Second-Generation PT/INR Monitoring System Receives FDA Clearance
April 2 (Reuters) - I Sens Inc 099190.KQ :
* COAG-SENSE® SECOND-GENERATION PT/INR MONITORING SYSTEM
RECEIVES
FDA CLEARANCE
Source text for Eikon: ID:nPn1TbQnBa
Further company coverage: 099190.KQ
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on I Sens
See all newsBrief: I Sens Inc Q3 Operating Profit 3.8 Billion Won, Up 314% From Year Earlier
Brief: I Sens Inc Q1 Operating Profit 813 Million Won, Down 75% From Year Earlier
Brief: I-Sens Q3 Operating Profit 1 Billion Won, Down 73.4% From Year Earlier
Brief: I-Sens To Cancel 2 Billion Won Worth Of Own Shares
Brief: I-Sens Q1 Operating Profit 3.2 Billion Won, Up 290% From Year Earlier